Markets:

Overview

News

Currencies

International

Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

13.16 -0.36 (-2.66%)

Delayed Quote Updated: 10:25 AM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Bioventus Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >

Bioventus (BVS) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Pain Treatments surged 11.5% as management explores strategic alternatives.

Via The Motley Fool

Topics Earnings

Bioventus Q2 Earnings Call Highlights ↗

August 05, 2026

Bioventus (NASDAQ:BVS) reported second-quarter 2026 revenue growth of 4% and reiterated its full-year financial outlook, citing double-digit expansion in its Pain Treatments business, continued debt...

Via MarketBeat

Topics Earnings

Bioventus (NASDAQ:BVS) Falls After Q2 Revenue Miss, Launches Strategic Review ↗

August 05, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's after-hours session. ↗

July 02, 2026

Via Chartmill

Bioventus Inc (NASDAQ:BVS) Smashes Q1 Estimates and Lifts Guidance, Shares Rally ↗

May 06, 2026

Via Chartmill

Bioventus Inc (NASDAQ:BVS) Reports Q4 Earnings Beat and Strong 2026 Outlook ↗

March 05, 2026

Via Chartmill

Topics Earnings

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls ↗

June 08, 2026

Bioventus (NASDAQ:BVS) executives outlined the company’s portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering...

Via MarketBeat

Topics Initial Public Offering

Bioventus (BVS) Q1 2026 Earnings Transcript ↗

May 06, 2026

Bioventus (BVS) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics World Trade

Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗

April 14, 2026

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Examining the Future: Bioventus's Earnings Outlook ↗

May 05, 2025

Via Benzinga

Bioventus (BVS) Q4 2025 Earnings Call Transcript ↗

March 05, 2026

Bioventus (BVS) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings World Trade

These stocks are gapping in today's session ↗

November 04, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Bioventus Inc (NASDAQ:BVS) Reports Q3 2025 Earnings Beat and Strong Profitability Growth ↗

November 04, 2025

Bioventus (BVS) reported strong Q3 2025 earnings, beating EPS estimates with a 200% surge. While revenue slightly missed, organic growth was up 8.2%.

Via Chartmill

Topics Earnings

Bioventus Inc. (NASDAQ:BVS) Reports Mixed Q2 2025 Earnings Amid Muted Market Reaction ↗

August 06, 2025

Bioventus Inc. (BVS) reports mixed Q2 2025 results with slight revenue miss but EPS near estimates. Organic growth up 6.2%, yet stock dips 2% pre-market.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 07, 2025

Via Benzinga

Gapping stocks in Tuesday's session ↗

March 11, 2025

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million ↗

March 11, 2025

Bioventus posted strong Q4 results, with EPS and revenue surpassing estimates. The company projects 2025 sales of $560M–$570M and adjusted EPS of $0.64–$0.68.

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

March 11, 2025

As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

Korn Ferry Posts Better-Than-Expected Earnings, Joins Bioventus, Endeavour Silver, Vail Resorts And Other Big Stocks Moving Higher On Tuesday ↗

March 11, 2025

Via Benzinga

Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings ↗

November 05, 2024

Via Benzinga

Topics Stocks

S&P 500 Gains 1%; Vimeo Shares Spike Higher ↗

November 05, 2024

Via Benzinga

Topics Stocks

Earnings Scheduled For March 11, 2025 ↗

March 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 05, 2024

Via Benzinga

Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September ↗

November 05, 2024

Via Benzinga

Solventum Stock Earns 81 RS Rating ↗

October 15, 2024

Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.

Via Investor's Business Daily

Executives Buying W. P. Carey And 2 Other Stocks ↗

August 21, 2024

Via Benzinga

BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

BVS stock results show that Bioventus beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Bioventus Inc. - Class A Common Stock (NQ:BVS)

Headline News about Bioventus Inc. - Class A Common Stock

Starting at /week.